Is Gland Pharma Ltd halal to invest in?

As of July 2026, Gland Pharma Ltd GLAND.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Gland Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gland Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Gland Pharma Ltd?

Muslim investors may consider investing in Gland Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Gland Pharma Ltd classified as HALAL?

Musaffa determines the Shariah status of Gland Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Gland Pharma Ltd updated?

The Shariah compliance status of Gland Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Gland Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Gland Pharma Ltd?

You can check the latest Shariah compliance status of Gland Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Gland Pharma Ltd GLAND.NS

Last Updated: Jul 21, 12:00 AM·NSE

GLAND.NS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Gland Pharma Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Gland Pharma Ltd. Stock Analysis GLAND.NS

India Health Care Mid Cap Report: 2026 Annual

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. The firm specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The firm manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. The company also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The firm functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.

Key Statistics of Gland Pharma Ltd (GLAND.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹2,417.40₹2,497.90

Today's Open

₹2,476.00

Volume

210.89K

P/E Ratio (TTM)

39.34

52 Week Range

₹1,573.60₹2,573.50

Market Cap

420.81B

Avg. Volume

721.33K

Dividend Yield

0.73%

Financial Metrics & Statements of Gland Pharma Ltd (GLAND.NS)

Super Investors Invested in Gland Pharma Ltd (GLAND.NS)

FAQ's for Gland Pharma Ltd (GLAND.NS)

As of July 2026, Gland Pharma Ltd GLAND.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gland Pharma Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Gland Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Gland Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Gland Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Gland Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.